Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2022-03-31 Governance Information
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE UNDER THE BOARD OF THE COMPANY
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of the Nomination Committee under the Board of the Company' and details the structure, duties, responsibilities, powers, rules of procedure, and reporting procedures of the Nomination Committee. It focuses on governance aspects such as board composition, nomination processes, and corporate governance policies. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related report outlining internal rules and committee functions, which aligns with the Governance Information category (CGR).
2022-03-31 English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE UNDER THE BOARD OF THE COMPANY
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of the Audit Committee under the Board of the Company' and details the composition, duties, and responsibilities of the Audit Committee. It extensively covers the committee's role in financial reporting, risk management, internal control systems, and internal audit functions. There are no actual financial statements, audit results, or financial performance data presented. Instead, it is a governance document outlining the audit committee's framework and responsibilities, which aligns with governance information rather than an audit report or annual report. Therefore, the document fits best under Governance Information (CGR). The document length is substantial and contains detailed governance policies, not a brief announcement or certification, so it is not RNS or RPA.
2022-03-31 English
ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is titled 'Articles of Association of RemeGen Co., Ltd.' and contains detailed chapters on company governance, share issuance, board structure, shareholder meetings, financial and accounting systems, and other corporate governance matters. It references relevant laws and regulations, including the Company Law of the People's Republic of China, Securities Law, and Hong Kong Listing Rules. The content is a comprehensive set of internal rules and regulations governing the company rather than a financial report, announcement, or meeting material. This matches the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is substantial (15,000 characters), indicating it is the full text of the Articles of Association, not a brief announcement or summary. Therefore, the appropriate classification is CGR with high confidence.
2022-03-31 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-03-30 English
INSIDE INFORMATION - COMPLETION OF THE A SHARE OFFERING
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of an A Share Offering by RemeGen Co., Ltd. It provides details about the listing on the Sci-tech Innovation Board of Shanghai Stock Exchange, including the date of listing, stock code, and share structure. The document is relatively short (3219 characters) and serves as an informational announcement rather than a detailed financial report or filing. It does not contain financial statements or detailed analysis but rather informs about the completion of a capital raising event and listing. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2022-03-30 English
INSIDE INFORMATION - PROGRESS OF THE PARTICIPATION IN THE STRATEGIC ALLOTMENT UNDER THE ISSUE OF A SHARES BY CONNECTED PERSONS
Capital/Financing Update Classification · 95% confidence The document is an announcement by RemeGen Co., Ltd. regarding the progress of participation in a strategic allotment under the issue of A shares by connected persons. It references prior announcements and an EGM approval related to the allotment of shares to senior management and core employees. The content is focused on the details of share allotment and participation percentages, which is related to capital raising and share issuance activities. The document is an announcement of the progress and details of a share allotment plan, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the allotment. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-03-30 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.